Venus Remedies gets oncology tender from PAHO

19 Jun 2024 Evaluate

Venus Remedies has been awarded an oncology tender by the WHO-backed Pan American Health Organisation (PAHO), the world’s oldest international public health agency, for supplying essential cancer drugs to multiple Latin American countries. This achievement signifies a major milestone for the company, enhancing its contribution to global health initiatives and reinforcing its commitment to improving global health outcomes by providing life-saving medicines to those who need them the most.

The company has been entrusted with the responsibility of supplying a wide range of essential oncology drugs like bleomycin, carboplatin, cisplatin, cytarabine, doxorubicin, irinotecan, methotrexate, and vincristine. This prestigious tender award highlights Venus Remedies' commitment to advancing healthcare and its crucial role in the global battle against cancer.

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.


Venus Remedies Share Price

745.20 -7.70 (-1.02%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×